(D28) A Blueprint for Integrating CGM in Primary Care: From Concept to Systemwide Adoption

Sunday, August 9, 2026

3:45 PM - 4:30 PM ET

CE: .75 CE

Continuous glucose monitoring is a cornerstone of diabetes care, yet primary care teams often face barriers in ordering devices, accessing data, and supporting patients effectively. This session highlights how the DCES can simplify complexity, bridge workflow gaps, and strengthen partnership with primary care. Using a real‑world train‑the‑trainer model and guided by the principles of the Law of Diffusion of Innovation to define scope and pace of adoption, we will explore the journey from concept and sponsorship to workflow mapping, tool creation, training, and rollout across 52 clinics. This blueprint shows how aligning DCES expertise with workflows enhances care, improves efficiency, supports billing, and strengthens systemwide consistency

Learning Objectives:

At the completion of this activity, participants should be able to:

Describe the essential steps in developing a systemwide CGM workflow, including process mapping, key partner engagement, and organizational sponsorship.
Apply strategies for integrating CGM processes into primary care using simplified workflows, EHR tools, and a Train‑the‑Trainer model.
Identify change‑management strategies that support clinic adoption and sustainability through champion development, workflow barrier reduction, and ongoing DCES engagement.

Disclosure(s):

Erin L. DaRosa, MBA, RDN, LD, CDCES: No financial relationships to disclose

Thomas W. Martens, MD: Abbott Diabetes Care: Consultant / Advisory Board (Ongoing), Research (Ongoing); Amgen: Research (Ongoing); Dexcom: Research (Ongoing); Eli Lilly: Consultant / Advisory Board (Ongoing), Research (Ongoing); Insulet: Research (Ongoing); Luna: Research (Ongoing); Mannkind: Consultant / Advisory Board (Ongoing); Medtronic: Research (Ongoing); Novo Nordisk: Research (Ongoing); Sanofi: Consultant / Advisory Board (Ongoing), Research (Ongoing); Sequel: Research (Ongoing); Tandem: Research (Ongoing); Zealand: Research (Ongoing)

Primary Presenter(s)

Erin L. DaRosa, MBA, RDN, LD, CDCES

Senior Manager Diabetes Education
HealthPartners

Disclosure(s): No financial relationships to disclose

Co-Presenter(s)

Thomas W. Martens, MD

Medical Director
International Diabetes Center- HealthPartners Institute

Disclosure(s): Abbott Diabetes Care: Consultant / Advisory Board (Ongoing), Research (Ongoing); Amgen: Research (Ongoing); Dexcom: Research (Ongoing); Eli Lilly: Consultant / Advisory Board (Ongoing), Research (Ongoing); Insulet: Research (Ongoing); Luna: Research (Ongoing); Mannkind: Consultant / Advisory Board (Ongoing); Medtronic: Research (Ongoing); Novo Nordisk: Research (Ongoing); Sanofi: Consultant / Advisory Board (Ongoing), Research (Ongoing); Sequel: Research (Ongoing); Tandem: Research (Ongoing); Zealand: Research (Ongoing)